LANDSCAPE IN GENE THERAPY COMPANIES – SEP 2019

“Landscape… in Gene Therapy Companies” provides you with an in-depth analysis of more than 230 companies involved in this expanding field.  (UPDATED SEP 2019)

In this 800-pages report, a must-have read one, you will find included:

 • More than 230 closely scrutinized companies
• More than 600 products identified
including more than 200 products at the clinical stage
• A Product Breakdown by Development Phase
 • More than 300 VC or investors mentioned
  • More than 250 pathologies referred.

 A Detailed Overview of Companies Involved in

 • AAV-based Gene Therapy
• LV-based Gene Therapy
• RNA-based Derived Drugs (RNAi, mRNA Therapeutics…)
 • Gene Editing Therapy
 • CDMO (Contract, Development and Manufacturing Organisation)
• Miscellaneous (Including Hubs and Non Viral Gene Transfer)

CAR-T strategies will be dealt separately in the updated edition of our briefing on CAR-T clinical trials. The 2019 edition will be published next November.

Each Technical Datasheet includes for Every Company

– General Informations (location, website, FTE, management with e-mail contacts)
– Core Business in Gene Therapy
– Financial Data (stock informations, market cap, financial highlights, recent fundings….)
– Pipeline (discovery, pre-clinical, phase I / II / III, marketed products)
– Orphan Drug Designations
– Clinical Trials
– Latest Developments in Gene Therapy
– Latest Publications 

Please click here to get  sample pages of Landscape in Gene Therapy Companies 2019

Please click here to get the ORDER FORM 50% discount for Landscape in Genetherapy companies 2019